Back to search
Non-Tuberculous Mycobacteria Pulmonary Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Tuberculous Mycobacteria Pulmonary Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Tuberculous Mycobacteria Pulmonary Disease trials you may qualify forThis double-blind, randomized, placebo-controlled, parallel-group, multicenter, prospective, investigator-initiated trial will evaluate epetraborole (EBO) monot…
A biomarker cohort study design is proposed to study whether specific airway microbiota alterations are associated with pulmonary Non-tuberculous mycobacteria (…
This multicenter, non-interventional case-control study investigates whether household environmental reservoirs, particularly water systems, are associated with…
The goal of this clinical trial is to learn if adding contezolid works to shorten the length of treatment in mycobacterium avium pulmonary disease in adults. It…
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NT…
Nontuberculous mycobacteria (NTM) are environmental organisms found in soil and water. The majority do not cause human disease. When they do, this is mostly as…
Background: \- Pulmonary nontuberculous mycobacterial infection is a respiratory infection that is sometimes difficult to diagnose. Proper diagnosis depends on…
The goal of this clinical trial is to learn if a new combination antibiotic treatment (Arm D) works to treat a rare lung condition called mycobacterium abscessu…
An increase in the prevalence of infections due to non-tuberculous mycobacteria (NTM) is observed in many countries and recent data suggest the circulation of d…